Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
According to Future Market Insights (FMI), the oxytocic pharmaceuticals market is likely to generate US$ 114.58 million in revenue in 2023. The oxytocic pharmaceuticals industry is anticipated to thrive at a 7.8% CAGR from 2023 to 2033, reaching US$ 242.83 million by 2033.
Due to the quick improvements in maternity care, expanding government programs, and rising rates of elective caesareans, growth estimates for Europe remain encouraging. With 31% of the region's oxytocic drug sales, Germany may hold a significant market share in Europe.
The primary factors fuelling market expansion are a rise in the tendency to give birth in hospitals rather than at home and an uptick in caesarian deliveries. The oxytocic pharmaceuticals sector is experiencing rivalry due to the variety of products supplied by companies related to oxytocic medications to gain market share. The unfavorable side effects of oxytocic drugs that produce excessive postpartum bleeding due to hemorrhage are the main factors preventing the oxytocic pharmaceutical sector from expanding.
Through license agreements, advancements in more recent oxytocic medications may promote sales. The demand for oxytocin pharmaceuticals may benefit from increased usage of antepartum oxytocin injection to stimulate uterine contractions.
Attribute | Details |
---|---|
Oxytocic Pharmaceuticals Market CAGR (2023 to 2033) | 7.8% |
Oxytocic Pharmaceuticals Market HCAGR (2018 to 2022) | 6% |
Oxytocic Pharmaceuticals Market Size - 2023 | US$ 114.58 million |
Oxytocic Pharmaceuticals Market Size - 2033 | US$ 242.83 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Between 2018 and 2022, the oxytocic pharmaceuticals industry captured a 6% CAGR, and it is anticipated that this pattern may hold from 2023 to 2033. Due to growing knowledge of the advantages of oxytocic medications in promoting labor and reducing postpartum hemorrhage, the market saw an increase in demand from 2018 to 2022. Raising birth rates in developing nations and improvements in healthcare facilities aided market expansion.
From 2023 to 2033, the market is expected to continue growing steadily. The market is anticipated to develop due to increased attention paid to maternal health, the rising occurrence of difficulties during childbirth, and the rise in government programs to upgrade healthcare facilities.
The efficacy and safety of oxytocic medications are projected to be improved by technological developments in drug formulations and delivery methods, leading to a rise in their use.
Overall, the market for oxytocic pharmaceuticals is anticipated to expand throughout the forecast period due to rising awareness, rising birth rates, and developments in the infrastructure and technology of the healthcare industry.
Brand names like Pitocin are used to advertise synthetic oxytocin. Artificial medications include derivatives of synthetic oxytocin. In today's market, oxytocin pills and injectables are easily accessible. The initial dose should be 0.5–1 mU/min (equivalent to 3-6 ml of the diluted Oxytocic solution per hour) when considering induction or stimulation of labor.
Oxytocic agents are drugs that stimulate uterine activity. They are used to induce labor, increase contractions, reduce the risk of postpartum hemorrhage right after delivery, and release fetal contents during incomplete abortions. To prevent the development of uterine atony, endogenous oxytocic drugs are also frequently given following C-sections.
Oxytocic drugs are administered intravenously or intramuscularly to treat postpartum hemorrhage, labor induction, and incomplete or unavoidable abortion. As a result of the increasing adoption of oxytocic pharmaceuticals, the market is expanding, adding to the industry outlook.
Companies functioning in the global oxytocic pharmaceuticals industry can reap more considerable market revenue from untapped markets in Asia and Africa. Here, the prevalence of postpartum hemorrhage is higher than in other regions.
Imparting awareness about pregnancy among the women in these regions can help create market opportunities for existing as well as new entrants in the global oxytocic medicines market.
The stringent regulatory structure that controls the manufacture and distribution of these medications is the primary constraint. The development of novel oxytocic medicines needs to be improved by the strict regulations and approval procedures established by regulatory agencies.
Smaller pharmaceutical companies have financial obstacles due to the high cost of these drugs' development, manufacture, and marketing, which further restrains market growth for oxytocic pharmaceuticals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Oxytocic Pharmaceuticals Market:
Attributes | Oxytocic Pharmaceuticals Market |
---|---|
CAGR (From 2023 to 2033) | 7.8% |
Market Value (2023) | US$ 114.58 million |
Growth Factor | Rising awareness of maternal health boosts oxytocic pharmaceutical demand. |
Opportunity | Technological innovations enhance oxytocic drug formulations. |
Key Trends | Government initiatives and infrastructure development drive market growth. |
Oxytocin Market:
Attributes | Oxytocin Market |
---|---|
CAGR (From 2023 to 2033) | 9% |
Market Value (2023) | US$ 90.47 million |
Growth Factor | Pharmaceuticals that promote labor and stop postpartum hemorrhage are in high demand. |
Opportunity | Developments are improving the efficacy and safety of oxytocic medications in drug formulation and delivery methods. |
Key Trends | Governments are taking action to enhance the healthcare system and improve maternity care. |
Ethical Pharmaceuticals Market:
Attributes | Ethical Pharmaceuticals Market |
---|---|
CAGR (From 2023 to 2033) | 5.07% |
Market Value (2023) | US$ 3.37 billion |
Growth Factor | Increasing demand for personalized medicine and targeted therapies in the ethical pharmaceuticals market. |
Opportunity | Growing focus on sustainability and environmental responsibility in pharmaceutical manufacturing practices. |
Key Trends | Advancements in biotechnology and gene therapies driving innovation and breakthroughs in ethical pharmaceuticals. |
In the upcoming years, the North American oxytocic medicines market is anticipated to expand steadily. Oxytocic medications are frequently used to initiate or speed up labor during childbirth as well as to prevent or manage postpartum hemorrhage. The rising occurrence of difficulties during work and the increasing demand for secure, efficient drugs in obstetrics are driving the market's expansion.
The market expansion is further fueled by the increased emphasis on enhancing maternal healthcare and the accessibility of cutting-edge oxytocic medications. To some extent, nevertheless, market expansion may be hampered by strict rules and expensive oxytocic drugs.
In the future, there may be a significant expansion in the Asia Pacific oxytocic medicines industry. Oxytocic medications are essential for accelerating labor and reducing postpartum hemorrhage. The growing emphasis on enhancing maternal healthcare and lowering maternal death rates is the main factor accelerating the market.
The market is expanding as a result of population growth, increased public awareness of the value of safe delivery techniques, and improvements in the healthcare system. However, issues including strict regulatory guidelines and restricted access to high-quality healthcare in some rural areas may impede the market expansion to some extent.
Due to the increased incidence of pregnancy problems and growing awareness of the importance of safe maternal healthcare, the market for oxytocic medications in Europe is now seeing a considerable increase in demand. Oxytocic medications, frequently used to hasten or speed up labor and treat postpartum hemorrhage, are becoming more widely used.
The availability of cutting-edge oxytocic medicines and improvements in medical technology are also boosting market expansion. However, the high cost of these pharmaceuticals and strict regulatory requirements are obstacles to the market's progress. Despite these obstacles, producers should have attractive prospects in the European oxytocic medicines market in the years to come.
Segment | Postpartum Haemorrhage |
---|---|
Segment Share | 75% |
The postpartum hemorrhage category holds more than 75% of the global oxytocic medicines market. By 2026, it is anticipated to increase its market share by more than 200 BPS. During the forecast period, the postpartum hemorrhage segment is expected to develop rapidly year over year and hold its position as the dominating segment.
The issue of postpartum bleeding is driven by the rise in births through labor induction. Pre-eclampsia is one occasion where extending the pregnancy could be harmful to the mother. Other times, women may feel uncomfortable, sore, or exhausted. When this happens, convenience over medical needs is the primary motivation for inducing labor. Postpartum hemorrhage risk rises with labor induction.
The World Health Organization states that labor induction rates are lower in developing nations but are substantially higher in developed countries, which has a favorable effect on the postpartum hemorrhage sector. The aging of mothers is another aspect predicted to contribute to the postpartum hemorrhage segment's revenue growth. After giving birth, heavy bleeding is more common in older and smoking women.
In virtually every region of the world, the rate of pregnancies after a particular age has increased, spurring growth in the postpartum hemorrhage section of the worldwide oxytocic drugs market.
Segment | Hospital |
---|---|
Segment Share | 67% |
With the leading market share of 67% in the end-use category of oxytocic medicines globally in 2020, the hospital segment is projected to attract more attention. Oxytocin is frequently utilized in prenatal medicine, although a high dose can have significant adverse consequences. Pregnant women who have labor pain and breastfeeding mothers both need perinatal medications. Oxytocin is administered intravenously in a hospital under medical supervision to start labor or amplify contractions.
Hospitals also utilize oxytocic medications for a variety of causes in obstetrics and obstetric anesthesia. As opposed to natural oxytocin, synthetic oxytocin is a medication that is frequently used. A high dose of synthetic oxytocin may also have several undesirable side effects on patients.
Compared to other clinics, hospitals tend to administer oxytocin more frequently. The increased availability of medications at hospital pharmacies is another crucial aspect driving the market's expansion.
The oxytocic pharmaceuticals market is characterized by fierce rivalry among several significant competitors. This competitive landscape examines both international and domestic firms.
These companies are employing a variety of measures to maintain their market shares, including mergers, acquisitions, collaborations, and new releases. Such approaches allow them to keep ahead of the competition and propel the oxytocin medicines sector forward.
Key Oxytocic Pharmaceuticals Manufacturers
Recent Breakthroughs and Developments
Company | Tonix Pharmaceuticals |
---|---|
Strategy | Tonix Pharmaceuticals granted the United States patent for intranasal oxytocin painkillers with magnesium-containing formulations |
Details | Tonix Pharmaceuticals was granted a United States patent in August 2022 for its intranasal Oxytocin (TNX-1900) painkiller. Intranasal magnesium-containing oxytocin formulations were claimed in the patent, named ‘Magnesium-Containing Oxytocin Formulations and Methods of Use,’ as well as methods and compositions for relieving pain, including those related to migraine headaches. With the probable exception of patent term extensions, this patent is anticipated to give Tonix in the United States market exclusivity until January 2036. |
Company | Drugs Controller General of India (DCGI) |
---|---|
Strategy | India allows the import of Oxytocin reference standards for testing |
Details | After submitting a test license provided by the Drugs Controller General of India (DCGI), the Central Government of India permitted the import of oxytocin reference standards for testing and analysis in May 2022. |
Company | Zentalis Pharmaceuticals |
---|---|
Strategy | Zentalis Pharmaceuticals announce US$ 25 million share sale to Pfizer |
Details | Zentalis Pharmaceuticals announced in April 2022 that it has agreed to sell 953,834 of its common shares to Pfizer for US$ 25.0 million (the Transaction). Pfizer received and purchased the common shares in a registered direct offering without the use of an underwriter or placement agent. |
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033 5.3.1. Abortion Induced Incomplete 5.3.2. Inevitable Abortion 5.3.3. Post-partum Haemorrhage 5.3.4. Labour Induction 5.3.5. Labour Arrest 5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of administration 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Route of administration, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of administration, 2023 to 2033 6.3.1. Intravenous Infusion/Injection 6.3.2. Intramuscular Injection 6.4. Y-o-Y Growth Trend Analysis By Route of administration, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Route of administration, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source of Origin 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Source of Origin , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source of Origin , 2023 to 2033 7.3.1. Natural Oxytocin 7.3.2. Synthetic Oxytocin Derivative 7.4. Y-o-Y Growth Trend Analysis By Source of Origin , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Source of Origin , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Maternity clinics 8.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Indication 10.2.3. By Route of administration 10.2.4. By Source of Origin 10.2.5. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Indication 10.3.3. By Route of administration 10.3.4. By Source of Origin 10.3.5. By End-User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Indication 11.2.3. By Route of administration 11.2.4. By Source of Origin 11.2.5. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Indication 11.3.3. By Route of administration 11.3.4. By Source of Origin 11.3.5. By End-User 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Indication 12.2.3. By Route of administration 12.2.4. By Source of Origin 12.2.5. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Indication 12.3.3. By Route of administration 12.3.4. By Source of Origin 12.3.5. By End-User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Indication 13.2.3. By Route of administration 13.2.4. By Source of Origin 13.2.5. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Indication 13.3.3. By Route of administration 13.3.4. By Source of Origin 13.3.5. By End-User 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Indication 14.2.3. By Route of administration 14.2.4. By Source of Origin 14.2.5. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Indication 14.3.3. By Route of administration 14.3.4. By Source of Origin 14.3.5. By End-User 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Indication 15.2.3. By Route of administration 15.2.4. By Source of Origin 15.2.5. By End-User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Indication 15.3.3. By Route of administration 15.3.4. By Source of Origin 15.3.5. By End-User 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Indication 16.2.3. By Route of administration 16.2.4. By Source of Origin 16.2.5. By End-User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Indication 16.3.3. By Route of administration 16.3.4. By Source of Origin 16.3.5. By End-User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Indication 17.1.2.2. By Route of administration 17.1.2.3. By Source of Origin 17.1.2.4. By End-User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Indication 17.2.2.2. By Route of administration 17.2.2.3. By Source of Origin 17.2.2.4. By End-User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Indication 17.3.2.2. By Route of administration 17.3.2.3. By Source of Origin 17.3.2.4. By End-User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Indication 17.4.2.2. By Route of administration 17.4.2.3. By Source of Origin 17.4.2.4. By End-User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Indication 17.5.2.2. By Route of administration 17.5.2.3. By Source of Origin 17.5.2.4. By End-User 17.6. United Kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Indication 17.6.2.2. By Route of administration 17.6.2.3. By Source of Origin 17.6.2.4. By End-User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Indication 17.7.2.2. By Route of administration 17.7.2.3. By Source of Origin 17.7.2.4. By End-User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Indication 17.8.2.2. By Route of administration 17.8.2.3. By Source of Origin 17.8.2.4. By End-User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Indication 17.9.2.2. By Route of administration 17.9.2.3. By Source of Origin 17.9.2.4. By End-User 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Indication 17.10.2.2. By Route of administration 17.10.2.3. By Source of Origin 17.10.2.4. By End-User 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Indication 17.11.2.2. By Route of administration 17.11.2.3. By Source of Origin 17.11.2.4. By End-User 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Indication 17.12.2.2. By Route of administration 17.12.2.3. By Source of Origin 17.12.2.4. By End-User 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Indication 17.13.2.2. By Route of administration 17.13.2.3. By Source of Origin 17.13.2.4. By End-User 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Indication 17.14.2.2. By Route of administration 17.14.2.3. By Source of Origin 17.14.2.4. By End-User 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Indication 17.15.2.2. By Route of administration 17.15.2.3. By Source of Origin 17.15.2.4. By End-User 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Indication 17.16.2.2. By Route of administration 17.16.2.3. By Source of Origin 17.16.2.4. By End-User 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Indication 17.17.2.2. By Route of administration 17.17.2.3. By Source of Origin 17.17.2.4. By End-User 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Indication 17.18.2.2. By Route of administration 17.18.2.3. By Source of Origin 17.18.2.4. By End-User 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Indication 17.19.2.2. By Route of administration 17.19.2.3. By Source of Origin 17.19.2.4. By End-User 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Indication 17.20.2.2. By Route of administration 17.20.2.3. By Source of Origin 17.20.2.4. By End-User 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Indication 17.21.2.2. By Route of administration 17.21.2.3. By Source of Origin 17.21.2.4. By End-User 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Indication 17.22.2.2. By Route of administration 17.22.2.3. By Source of Origin 17.22.2.4. By End-User 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Indication 17.23.2.2. By Route of administration 17.23.2.3. By Source of Origin 17.23.2.4. By End-User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Indication 18.3.3. By Route of administration 18.3.4. By Source of Origin 18.3.5. By End-User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Pfizer, Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Fresenius Kabi AG 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Novartis AG 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Cardinal Health 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Ferring Pharmaceuticals B.V. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Par Sterile Products, LLC (Endo International plc) 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Teva Pharmaceutical Industries 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Biofutura 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Baxter Healthcare 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Hikma Pharmaceuticals PLC 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 13: Latin America Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 14: Latin America Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: Western Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 18: Western Europe Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 19: Western Europe Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 20: Western Europe Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 21: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: Eastern Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 23: Eastern Europe Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 24: Eastern Europe Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 25: Eastern Europe Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 26: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 27: South Asia and Pacific Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 28: South Asia and Pacific Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 29: South Asia and Pacific Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 30: South Asia and Pacific Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 31: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: East Asia Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 33: East Asia Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 34: East Asia Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 35: East Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 36: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 37: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 38: Middle East and Africa Market Value (US$ Million) Forecast by Route of administration, 2018 to 2033 Table 39: Middle East and Africa Market Value (US$ Million) Forecast by Source of Origin , 2018 to 2033 Table 40: Middle East and Africa Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Indication, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by End-User, 2023 to 2033 Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 10: Global Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 11: Global Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 12: Global Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 13: Global Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 14: Global Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 15: Global Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 16: Global Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 17: Global Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 18: Global Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 21: Global Market Attractiveness by Indication, 2023 to 2033 Figure 22: Global Market Attractiveness by Route of administration, 2023 to 2033 Figure 23: Global Market Attractiveness by Source of Origin , 2023 to 2033 Figure 24: Global Market Attractiveness by End-User, 2023 to 2033 Figure 25: Global Market Attractiveness by Region, 2023 to 2033 Figure 26: North America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 27: North America Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 28: North America Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 29: North America Market Value (US$ Million) by End-User, 2023 to 2033 Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 40: North America Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 46: North America Market Attractiveness by Indication, 2023 to 2033 Figure 47: North America Market Attractiveness by Route of administration, 2023 to 2033 Figure 48: North America Market Attractiveness by Source of Origin , 2023 to 2033 Figure 49: North America Market Attractiveness by End-User, 2023 to 2033 Figure 50: North America Market Attractiveness by Country, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 52: Latin America Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 53: Latin America Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) by End-User, 2023 to 2033 Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 59: Latin America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 62: Latin America Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 68: Latin America Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 69: Latin America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 71: Latin America Market Attractiveness by Indication, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Route of administration, 2023 to 2033 Figure 73: Latin America Market Attractiveness by Source of Origin , 2023 to 2033 Figure 74: Latin America Market Attractiveness by End-User, 2023 to 2033 Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 76: Western Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 77: Western Europe Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 78: Western Europe Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 79: Western Europe Market Value (US$ Million) by End-User, 2023 to 2033 Figure 80: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 81: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 84: Western Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 87: Western Europe Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 90: Western Europe Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 93: Western Europe Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 94: Western Europe Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 96: Western Europe Market Attractiveness by Indication, 2023 to 2033 Figure 97: Western Europe Market Attractiveness by Route of administration, 2023 to 2033 Figure 98: Western Europe Market Attractiveness by Source of Origin , 2023 to 2033 Figure 99: Western Europe Market Attractiveness by End-User, 2023 to 2033 Figure 100: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: Eastern Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 102: Eastern Europe Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 103: Eastern Europe Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 104: Eastern Europe Market Value (US$ Million) by End-User, 2023 to 2033 Figure 105: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 106: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 112: Eastern Europe Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 115: Eastern Europe Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 118: Eastern Europe Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 121: Eastern Europe Market Attractiveness by Indication, 2023 to 2033 Figure 122: Eastern Europe Market Attractiveness by Route of administration, 2023 to 2033 Figure 123: Eastern Europe Market Attractiveness by Source of Origin , 2023 to 2033 Figure 124: Eastern Europe Market Attractiveness by End-User, 2023 to 2033 Figure 125: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 126: South Asia and Pacific Market Value (US$ Million) by Indication, 2023 to 2033 Figure 127: South Asia and Pacific Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 128: South Asia and Pacific Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 129: South Asia and Pacific Market Value (US$ Million) by End-User, 2023 to 2033 Figure 130: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 131: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 132: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 133: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 134: South Asia and Pacific Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 138: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 139: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 140: South Asia and Pacific Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 141: South Asia and Pacific Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 142: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 143: South Asia and Pacific Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 144: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 145: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 146: South Asia and Pacific Market Attractiveness by Indication, 2023 to 2033 Figure 147: South Asia and Pacific Market Attractiveness by Route of administration, 2023 to 2033 Figure 148: South Asia and Pacific Market Attractiveness by Source of Origin , 2023 to 2033 Figure 149: South Asia and Pacific Market Attractiveness by End-User, 2023 to 2033 Figure 150: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 151: East Asia Market Value (US$ Million) by Indication, 2023 to 2033 Figure 152: East Asia Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 153: East Asia Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 154: East Asia Market Value (US$ Million) by End-User, 2023 to 2033 Figure 155: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 156: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 157: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 158: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 159: East Asia Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 160: East Asia Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 161: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 162: East Asia Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 163: East Asia Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 165: East Asia Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 166: East Asia Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 167: East Asia Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 168: East Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 169: East Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 170: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 171: East Asia Market Attractiveness by Indication, 2023 to 2033 Figure 172: East Asia Market Attractiveness by Route of administration, 2023 to 2033 Figure 173: East Asia Market Attractiveness by Source of Origin , 2023 to 2033 Figure 174: East Asia Market Attractiveness by End-User, 2023 to 2033 Figure 175: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 176: Middle East and Africa Market Value (US$ Million) by Indication, 2023 to 2033 Figure 177: Middle East and Africa Market Value (US$ Million) by Route of administration, 2023 to 2033 Figure 178: Middle East and Africa Market Value (US$ Million) by Source of Origin , 2023 to 2033 Figure 179: Middle East and Africa Market Value (US$ Million) by End-User, 2023 to 2033 Figure 180: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 182: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 183: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 184: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 185: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 186: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 187: Middle East and Africa Market Value (US$ Million) Analysis by Route of administration, 2018 to 2033 Figure 188: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of administration, 2023 to 2033 Figure 189: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of administration, 2023 to 2033 Figure 190: Middle East and Africa Market Value (US$ Million) Analysis by Source of Origin , 2018 to 2033 Figure 191: Middle East and Africa Market Value Share (%) and BPS Analysis by Source of Origin , 2023 to 2033 Figure 192: Middle East and Africa Market Y-o-Y Growth (%) Projections by Source of Origin , 2023 to 2033 Figure 193: Middle East and Africa Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 194: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 195: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 196: Middle East and Africa Market Attractiveness by Indication, 2023 to 2033 Figure 197: Middle East and Africa Market Attractiveness by Route of administration, 2023 to 2033 Figure 198: Middle East and Africa Market Attractiveness by Source of Origin , 2023 to 2033 Figure 199: Middle East and Africa Market Attractiveness by End-User, 2023 to 2033 Figure 200: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports